Genetic Basis of Hirschsprung's Disease

Overview

Journal Pediatr Surg Int

Specialties General Surgery
Pediatrics

Date 2009 Jun 13

PMID 19521704

Citations 44

Authors

Paul K H Tam

Merce Garcia-Barcelo

Affiliations

Soon will be listed here.

Abstract

Hirschsprung's disease (HSCR) is a developmental disorder characterized by the absence of ganglion cells in the lower digestive tract. Aganglionosis is attributed to a disorder of the enteric nervous system (ENS) whereby ganglion cells fail to innervate the lower gastrointestinal tract during embryonic development. HSCR is a complex disease that results from the interaction of several genes and manifests with low, sex-dependent penetrance and variability in the length of the aganglionic segment. The genetic complexity observed in HSCR can be conceptually understood in light of the molecular and cellular events that take place during the ENS development. DNA alterations in any of the genes involved in the ENS development may interfere with the colonization process, and represent a primary etiology for HSCR. This review will focus on the genes known to be involved in HSCR pathology, how they interact, and on how technology advances are being employed to uncover the pathological processes underlying this disease.

Citing Articles

Hirschsprung disease.

Montalva L, Cheng L, Kapur R, Langer J, Berrebi D, Kyrklund K Nat Rev Dis Primers. 2023; 9(1):54.

PMID: 37828049 DOI: 10.1038/s41572-023-00465-y.

A New Transgenic Tool to Study the Ret Signaling Pathway in the Enteric Nervous System.

Bandla A, Melancon E, Taylor C, Davidson A, Eisen J, Ganz J Int J Mol Sci. 2022; 23(24).

PMID: 36555308 PMC: 9779438. DOI: 10.3390/ijms232415667.

Identification and validation of the common pathogenesis and hub biomarkers in Hirschsprung disease complicated with Crohn's disease.

Wang J, Li Z, Xiao J, Wu L, Chen K, Zhu T Front Immunol. 2022; 13:961217.

PMID: 36248794 PMC: 9555215. DOI: 10.3389/fimmu.2022.961217.

Probiotics for the prevention of Hirschsprung-associated enterocolitis.

Mei F, Wu M, Zhao L, Hu K, Gao Q, Chen F Cochrane Database Syst Rev. 2022; 4:CD013714.

PMID: 35470864 PMC: 9039968. DOI: 10.1002/14651858.CD013714.pub2.

Enteric nervous system modulation of luminal pH modifies the microbial environment to promote intestinal health.

Hamilton M, Wall E, Robinson C, Guillemin K, Eisen J PLoS Pathog. 2022; 18(2):e1009989.

PMID: 35143593 PMC: 8830661. DOI: 10.1371/journal.ppat.1009989.

References

Garcia-Barcelo M, Ganster R, Lui V, Leon T, So M, Lau A . TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease. Hum Mol Genet. 2004; 14(2):191-204. DOI: 10.1093/hmg/ddi015. View

Pingault V, Girard M, Bondurand N, Dorkins H, Van Maldergem L, Mowat D . SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism. Hum Genet. 2002; 111(2):198-206. DOI: 10.1007/s00439-002-0765-8. View

Doray B, Salomon R, Amiel J, Pelet A, Touraine R, Billaud M . Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet. 1998; 7(9):1449-52. DOI: 10.1093/hmg/7.9.1449. View

Pingault V, Guiochon-Mantel A, Bondurand N, Faure C, Lacroix C, Lyonnet S . Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: a developmental "neural crest syndrome" related to a SOX10 mutation. Ann Neurol. 2000; 48(4):671-6. View

Reynolds L, Eng C . RET mutations in multiple endocrine neoplasia type 2 and Hirschsprung disease. Curr Opin Pediatr. 1995; 7(6):702-9. DOI: 10.1097/00008480-199512000-00014. View

Moore M, Klein R, Farinas I, Sauer H, Armanini M, Phillips H . Renal and neuronal abnormalities in mice lacking GDNF. Nature. 1996; 382(6586):76-9. DOI: 10.1038/382076a0. View

Donghi R, Sozzi G, Pierotti M, Biunno I, Miozzo M, Fusco A . The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). Oncogene. 1989; 4(4):521-3. View

Badner J, SIEBER W, GARVER K, Chakravarti A . A genetic study of Hirschsprung disease. Am J Hum Genet. 1990; 46(3):568-80. PMC: 1683643. View

Wakamatsu N, Yamada Y, Yamada K, Ono T, Nomura N, Taniguchi H . Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet. 2001; 27(4):369-70. DOI: 10.1038/86860. View

10.

SWENSON O . Early history of the therapy of Hirschsprung's disease: facts and personal observations over 50 years. J Pediatr Surg. 1996; 31(8):1003-8. DOI: 10.1016/s0022-3468(96)90074-3. View

11.

Borrego S, Wright F, Fernandez R, Williams N, Lopez-Alonso M, Davuluri R . A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Am J Hum Genet. 2002; 72(1):88-100. PMC: 420016. DOI: 10.1086/345466. View

12.

Kusafuka T, Puri P . Mutations of the endothelin-B receptor and endothelin-3 genes in Hirschsprung's disease. Pediatr Surg Int. 1997; 12(1):19-23. DOI: 10.1007/BF01194795. View

13.

Kruger G, Mosher J, Tsai Y, Yeager K, Iwashita T, Gariepy C . Temporally distinct requirements for endothelin receptor B in the generation and migration of gut neural crest stem cells. Neuron. 2003; 40(5):917-29. DOI: 10.1016/s0896-6273(03)00727-x. View

14.

Fu M, Lui V, Sham M, Cheung A, Tam P . HOXB5 expression is spatially and temporarily regulated in human embryonic gut during neural crest cell colonization and differentiation of enteric neuroblasts. Dev Dyn. 2003; 228(1):1-10. DOI: 10.1002/dvdy.10350. View

15.

Sancandi M, Ceccherini I, Costa M, Fava M, Chen B, Wu Y . Incidence of RET mutations in patients with Hirschsprung's disease. J Pediatr Surg. 2000; 35(1):139-42; discussion 142-3. DOI: 10.1016/s0022-3468(00)80031-7. View

16.

Barlow A, de Graaff E, Pachnis V . Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET. Neuron. 2003; 40(5):905-16. DOI: 10.1016/s0896-6273(03)00730-x. View

17.

Kusafuka T, Wang Y, Puri P . Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung's disease. Hum Mol Genet. 1996; 5(3):347-9. DOI: 10.1093/hmg/5.3.347. View

18.

Abe Y, Sakurai T, Yamada T, Nakamura T, Yanagisawa M, Goto K . Functional analysis of five endothelin-B receptor mutations found in human Hirschsprung disease patients. Biochem Biophys Res Commun. 2000; 275(2):524-31. DOI: 10.1006/bbrc.2000.3291. View

19.

Gath R, Goessling A, Keller K, Koletzko S, Coerdt W, Muntefering H . Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease. Gut. 2001; 48(5):671-5. PMC: 1728268. DOI: 10.1136/gut.48.5.671. View

20.

Benailly H, Lapierre J, Laudier B, Amiel J, Attie T, de Blois M . PMX2B, a new candidate gene for Hirschsprung's disease. Clin Genet. 2003; 64(3):204-9. DOI: 10.1034/j.1399-0004.2003.00105.x. View